US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 18, 2012 (14 years ago)

Copaxone

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

What was recalled

Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

Recalling firm
Teva Pharmaceuticals USA, Inc.
NDC code
68546-317-30
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1442-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glatiramer recalls

See all
Class II · Moderate risk Terminated

Copaxone

Reason Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.

Teva Pharmaceuticals USA NDC 68546-317-30 D-001-2014
Class II · Moderate risk Terminated

Copaxone

Reason Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.

Teva Pharmaceuticals USA, Inc. NDC 68546-317-30 D-249-2013